Sampling and diversity of Escherichia coli from the enteric microbiota in patients with Escherichia coli bacteraemia

BMC Res Notes. 2019 Jun 13;12(1):335. doi: 10.1186/s13104-019-4369-y.

Abstract

Objective: The increase in Escherichia coli bloodstream infections mandates better characterisation of the relationship between commensal and invasive isolates. This study adopted a simple approach to characterize E. coli in the gut reservoir from patients with either E. coli or other Gram-negative bacteraemia, or those without bacteraemia, establishing strain collections suitable for genomic investigation. Enteric samples from patients in the three groups were cultured on selective chromogenic agar. Genetic diversity of prevailing E. coli strains in gut microbiota was estimated by RAPD-PCR.

Results: Enteric samples from E. coli bacteraemia patients yielded a median of one E. coli RAPD pattern (range 1-4) compared with two (range 1-5) from groups without E. coli bacteraemia. Of relevance to large-scale clinical studies, observed diversity of E. coli among hospitalised patients was not altered by sample type (rectal swab or stool), nor by increasing the colonies tested from 10 to 20. Hospitalised patients demonstrated an apparently limited diversity of E. coli in the enteric microbiota and this was further reduced in those with E. coli bacteraemia. The reduced diversity of E. coli within the gut during E. coli bacteraemia raises the possibility that dominant strains may outcompete other lineages in patients with bloodstream infection.

Keywords: Bacteraemia; Diversity; Escherichia coli; Microbiota; RAPD; Rectal swab; Sepsis; Stool.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / drug therapy
  • Bacteremia / microbiology*
  • Cohort Studies
  • Escherichia coli / classification
  • Escherichia coli / drug effects
  • Escherichia coli / genetics*
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology*
  • Feces / microbiology*
  • Gastrointestinal Microbiome / genetics*
  • Genetic Variation*
  • Humans
  • Polymerase Chain Reaction / methods
  • Random Amplified Polymorphic DNA Technique / methods
  • Reproducibility of Results

Substances

  • Anti-Bacterial Agents